August 27, 2020
PAR-18-940 - Clinical and Translational Science Award (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this notice is to inform interested applicants in a change to the Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)”. The August 15, 2021 receipt date has been moved to July 15, 2021. Changes are shown below in bold italics.
Currently Reads:
Part 1. Overview Information
Key Dates
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
January 25, 2019, April 15, 2019, August 15, 2019, December 16, 2019, April 15, 2020, August 17, 2020, December 15, 2020, April 15, 2021, August 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Expiration Date |
August 16, 2021 |
Modified to Read:
Part 1. Overview Information
Key Dates
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
January 25, 2019, April 15, 2019, August 15, 2019, December 16, 2019, April 15, 2020, August 17, 2020, December 15, 2020, April 15, 2021, July 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Expiration Date |
July 16, 2021 |
All other aspects of this FOA remain unchanged.
Erica Rosemond, Ph.D
National Center for Advancing Translational Services (NCATS)
Telephone: 301-594-8927
Email: [email protected]